美国 · SEC FORM 4
Oric Pharmaceuticals, Inc.
ORIC · Nasdaq · CIK 0001796280 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
15 同一窗口内观察到的 Form 4 交易行
9 sales · 6 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-06-23 · You Angie.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 16,315,970
- 上期报告
- 17,532,473
- 日均成交量
- 1,655,964
- 回补天数
- 9.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-06-23 | You Angie | 买入 (P) | Common Stock | 1,403 | USD 9.43 | USD 13,230 | SEC 申报 ↗ |
| 2025-06-20 | You Angie | 买入 (P) | Common Stock | 26,597 | USD 9.39 | USD 249,746 | SEC 申报 ↗ |
| 2022-05-13 | Chacko Jacob | 买入 (P) | Common Stock | 76,072 | USD 2.82 | USD 214,523 | SEC 申报 ↗ |
| 2022-05-12 | Chacko Jacob | 买入 (P) | Common Stock | 69,354 | USD 2.75 | USD 190,724 | SEC 申报 ↗ |
| 2022-05-11 | Chacko Jacob | 买入 (P) | Common Stock | 304,574 | USD 2.90 | USD 883,265 | SEC 申报 ↗ |
| 2022-03-31 | Piscitelli Dominic | 买入 (P) | Common Stock | 60,000 | USD 5.36 | USD 321,600 | SEC 申报 ↗ |
| 2022-03-25 | Chacko Jacob | 买入 (P) | Common Stock | 50,000 | USD 4.54 | USD 227,000 | SEC 申报 ↗ |
| 2022-03-24 | Chacko Jacob | 买入 (P) | Common Stock | 42,873 | USD 5.03 | USD 215,651 | SEC 申报 ↗ |
| 2022-03-23 | Chacko Jacob | 买入 (P) | Common Stock | 257,127 | USD 4.98 | USD 1,280,492 | SEC 申报 ↗ |
| 2020-04-24 | ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC | 买入 (P) | Common Stock | 281,250 | USD 16.00 | USD 4,500,000 | SEC 申报 ↗ |
| 2020-04-24 | GORDON CARL L | 买入 (P) | Common Stock | 281,250 | USD 16.00 | USD 4,500,000 | SEC 申报 ↗ |
Form 4 申报证据
27 transaction lines in the latest 365-day window; 189 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Heyman Richard A. | 卖出 (S) | Common Stock | 6,700 | USD 12.91 | USD 86,524 | SEC 申报 ↗ |
| 2026-10-01 | Heyman Richard A. | 期权行权／转换 (M) | Common Stock | 3,500 | USD 1.60 | USD 5,600 | SEC 申报 ↗ |
| 2026-09-28 | Piscitelli Dominic | 卖出 (S) | Common Stock | 13,400 | USD 13.53 | USD 181,302 | SEC 申报 ↗ |
展开近期 Form 4 证据 (22 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Heyman Richard A. | 卖出 (S) | Common Stock | 6,700 | USD 12.91 | USD 86,524 | SEC 申报 ↗ |
| 2026-10-01 | Heyman Richard A. | 期权行权／转换 (M) | Common Stock | 3,500 | USD 1.60 | USD 5,600 | SEC 申报 ↗ |
| 2026-09-28 | Piscitelli Dominic | 卖出 (S) | Common Stock | 13,400 | USD 13.53 | USD 181,302 | SEC 申报 ↗ |
| 2026-09-28 | Piscitelli Dominic | 期权行权／转换 (M) | Common Stock | 13,400 | USD 4.36 | USD 58,424 | SEC 申报 ↗ |
| 2026-09-24 | Piscitelli Dominic | 卖出 (S) | Common Stock | 600 | USD 13.51 | USD 8,105 | SEC 申报 ↗ |
| 2026-09-24 | Piscitelli Dominic | 期权行权／转换 (M) | Common Stock | 600 | USD 4.36 | USD 2,616 | SEC 申报 ↗ |
| 2026-08-26 | Piscitelli Dominic | 卖出 (S) | Common Stock | 77,000 | USD 13.69 | USD 1,054,130 | SEC 申报 ↗ |
| 2026-08-26 | Piscitelli Dominic | 期权行权／转换 (M) | Common Stock | 77,000 | USD 4.89 | USD 376,720 | SEC 申报 ↗ |
| 2026-07-24 | Heyman Richard A. | 卖出 (S) | Common Stock | 13,100 | USD 12.02 | USD 157,462 | SEC 申报 ↗ |
| 2026-07-24 | Heyman Richard A. | 期权行权／转换 (M) | Common Stock | 3,500 | USD 1.60 | USD 5,600 | SEC 申报 ↗ |
| 2026-07-06 | Heyman Richard A. | 卖出 (S) | Common Stock | 300 | USD 12.00 | USD 3,600 | SEC 申报 ↗ |
| 2026-02-24 | Piscitelli Dominic | 卖出 (S) | Common Stock | 52,000 | USD 13.51 | USD 702,520 | SEC 申报 ↗ |
| 2026-02-24 | Piscitelli Dominic | 期权行权／转换 (M) | Common Stock | 52,000 | USD 4.36 | USD 226,720 | SEC 申报 ↗ |
| 2026-01-16 | Heyman Richard A. | 卖出 (S) | Common Stock | 6,700 | USD 12.00 | USD 80,400 | SEC 申报 ↗ |
| 2025-12-16 | Piscitelli Dominic | 卖出 (S) | Common Stock | 10,720 | USD 9.06 | USD 97,123 | SEC 申报 ↗ |
| 2025-12-16 | Multani Pratik S | 卖出 (S) | Common Stock | 10,720 | USD 9.06 | USD 97,123 | SEC 申报 ↗ |
| 2025-12-16 | Chacko Jacob | 卖出 (S) | Common Stock | 33,374 | USD 9.06 | USD 302,368 | SEC 申报 ↗ |
| 2025-12-15 | Piscitelli Dominic | 期权行权／转换 (M) | Common Stock | 29,333 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-15 | Multani Pratik S | 期权行权／转换 (M) | Common Stock | 29,333 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-15 | Chacko Jacob | 期权行权／转换 (M) | Common Stock | 83,666 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-08 | Kunkel Lori Anne | 期权行权／转换 (M) | Common Stock | 10,000 | USD 7.90 | USD 79,000 | SEC 申报 ↗ |
| 2025-12-04 | Kunkel Lori Anne | 期权行权／转换 (M) | Common Stock | 5,534 | USD 3.75 | USD 20,752 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ORIC |
| CIK | 0001796280 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 189 transaction lines from 2020-04-24 to 2026-10-01 11 P purchase lines · 125 S sale lines · 53 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.